Arovella Therapeutics thanks retiring director David Simmonds for his service

Arovella Therapeutics Ltd (ASX:ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell platform to treat cancer has...

Related Keywords

London ,City Of ,United Kingdom ,Tom Duthy ,David Simmonds ,Michael Baker ,Imperial College London ,Arovella Therapeutics Ltd ,General Meeting ,Chimeric Antigen Receptor ,